Literature DB >> 20478501

Inflammatory bowel disease.

Eva Szigethy1, Laura McLafferty, Alka Goyal.   

Abstract

This article reviews the etiology, clinical characteristics, and treatment of inflammatory bowel disease (IBD) and associated psychological sequelae in children and adolescents with this lifelong disease. Pediatric-onset IBD, consisting of Crohn's disease and ulcerative colitis, has significant medical morbidity and in many young persons is also associated with psychological and psychosocial challenges. Depression and anxiety are particularly prevalent and have a multifaceted etiology, including IBD-related factors such as cytokines and steroids used to treat IBD and psychosocial stress. A growing number of empirically supported interventions, such as cognitive behavioral therapy, hypnosis, and educational resources, help youth and their parents cope with IBD as well as the psychological and psychosocial sequelae. While there is convincing evidence that such interventions can help improve anxiety, depression, and health-related quality of life, their effects on IBD severity and course await further study. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478501     DOI: 10.1016/j.chc.2010.01.007

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  19 in total

1.  Patient-Reported Outcomes Measurement Information System in Children with Crohn's Disease.

Authors:  Marina Arvanitis; Darren A DeWalt; Christopher F Martin; Millie D Long; Wenli Chen; Beth Jaeger; Robert S Sandler; Michael D Kappelman
Journal:  J Pediatr       Date:  2016-05-02       Impact factor: 4.406

2.  Impact of inflammatory bowel disease and high-dose steroid exposure on pupillary responses to negative information in pediatric depression.

Authors:  Neil P Jones; Greg J Siegle; Lindsay Proud; Jennifer S Silk; Diana Hardy; David J Keljo; Ronald E Dahl; Eva Szigethy
Journal:  Psychosom Med       Date:  2011-01-07       Impact factor: 4.312

3.  Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations.

Authors:  Paul A Rufo; Lee A Denson; Francisco A Sylvester; Eva Szigethy; Pushpa Sathya; Ying Lu; Ghassan T Wahbeh; Laureen M Sena; William A Faubion
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-07       Impact factor: 2.839

4.  Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease.

Authors:  David Benhayon; Ada Youk; F Nicole McCarthy; Stephanie Davis; David J Keljo; Athos Bousvaros; Diane Fairclough; David Kupfer; Daniel J Buysse; Eva M Szigethy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

Review 5.  Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Laura M Mackner; Rachel Neff Greenley; Eva Szigethy; Michele Herzer; Kate Deer; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-04       Impact factor: 2.839

6.  Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease.

Authors:  Rona L Levy; Miranda A L van Tilburg; Shelby L Langer; Joan M Romano; Lynn S Walker; Lloyd A Mancl; Tasha B Murphy; Robyn L Claar; Shara I Feld; Dennis L Christie; Bisher Abdullah; Melissa M DuPen; Kimberly S Swanson; Melissa D Baker; Susan A Stoner; William E Whitehead
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

Review 7.  Inflammatory bowel disease in patients with Hirschsprung's disease: a systematic review and meta-analysis.

Authors:  H Nakamura; T Lim; P Puri
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

8.  Health-related quality of life in adolescents with inflammatory bowel disease depends on disease activity and psychiatric comorbidity.

Authors:  G Engelmann; D Erhard; M Petersen; P Parzer; A A Schlarb; F Resch; R Brunner; G F Hoffmann; H Lenhartz; A Richterich
Journal:  Child Psychiatry Hum Dev       Date:  2015-04

9.  Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy.

Authors:  G Tomasello; C Sciumé; F Rappa; V Rodolico; M Zerilli; A Martorana; G Cicero; R De Luca; P Damiani; F M Accardo; M Romeo; F Farina; G Bonaventura; G Modica; G Zummo; E Conway de Macario; A J L Macario; F Cappello
Journal:  Eur J Histochem       Date:  2011-10-24       Impact factor: 3.188

10.  MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis.

Authors:  Nengtai Ouyang; Caihua Zhu; Dingying Zhou; Ting Nie; Mae F Go; Robert J Richards; Basil Rigas
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.